Harbin in Northeast China's Heilongjiang Province has experienced a recent boom in its tourism sector, boosting listed companies related to the tourism sector.
The popularity of Harbin has had a significant impact in the field of winter tourism. Stocks related to tourism, such as Dalian Sunasia Tourism Holding and Changbai Mountain Tourism Co have surged in recent days. Other tourism-related stocks, including Wuhan Sante Cableway Group Co and Zhang Jia Jie Tourism Group Co, have also followed the upward trend.
Changbai Mountain Tourism Co disclosed in a filing on Thursday that Changbai Mountain scenic area in Northeast China's Jilin Province reported a year-on-year increase of 260.5 percent in the number of tourists in 2023, a 9.4 percent increase compared to the same period in 2019.
In addition to the tourism sector, shares related to the revitalization of Northeast China also remained active in the stock market. Companies such as Heilongjiang Transport Development Co, Longjian Road & Bridge Co, and Zhongxing Shenyang Commercial Building Group Co saw significant gains in Thursday trading.
Harbin has been trending on various platforms, attracting a large number of tourists for its snow activities and the hospitality of local people.
According to data from the local tourism bureau, during the New Year’s Day holidays, Harbin received a record-breaking 3.04 million tourist visits, generating total tourism revenue of 5.91 billion yuan ($826.48 million). This marks a high point, both in the number of tourists and tourism revenue.
Harbin Taiping International Airport also achieved a new high in 2023, handling a total passenger throughput of 20.80 million, surpassing the previous record of 20.78 million in 2019.
The positive trend extends beyond Harbin to the entire province of Heilongjiang. During the New Year’s Day holidays, the province received a total of 6.61 million tourist visits, a year-on-year increase of 173.7 percent, surpassing the national growth rate by 18.4 percentage points. Tourism revenue in Heilongjiang reached 6.92 billion yuan, a year-on-year increase of 364.7 percent, surpassing the national growth rate by 164 percentage points.
China's veteran short track speed skater Fan Kexin kissed the ice surface at the Capital Indoor Stadium again on December 9 at the ISU Short Track World Cup in Beijing, as she returned to competition after a nearly two-year hiatus after the Beijing 2022 Winter Olympics.
Fan, who is among China's squad that won a gold medal in the 2,000-meter mixed relay at the home Olympics, finished her events on Saturday with two silver medals.
Fan clocked the women's 500 meters with 43.117 seconds, followed by her younger teammate Wang Ye with 43.176 seconds. At the awarding ceremony for the race, Fans kissed the ice surface again.
"I just love this ice so much," Fan, a three-time Olympian, told reporters after Saturday's races at the ISU short track World Cup event in Beijing. "As long as I have chances to compete, I will do my best."
Fan noted that now she is enjoying skating, thanks to the overwhelming support from Chinese fans.
"Their support means a lot to us. Now we are receiving massive attention from the fans compared to the past, which also boosted our confidence and performances," the 30-year-old said.
Fan's kiss on the ice surface at the Olympics was remembered as one of the emotional moments at the quadrennial event by Chinese short track fans.
Speculation was rampant that the Beijing 2022 Winter Olympics would be Fan's swansong, as she had not participated in any competition since.
Her return has been considered a boost for the Chinese women's short track team, which is currently in a rebuilding phase as it aims to return to the sport's top-tier.
Along with her younger teammates, Fan is also among the team that won a silver medal in the 2,000-meter mixed relay at the World Cup event. Her younger teammate Wang, who is just 18, has welcomed her return, crediting Fan who "strengthened" the whole team's confidence with competing.
Speaking about the winning inheritance of the short track team, which is the most successful Chinese winter sports team, Fan said it is not just "talk the talk."
"The inheritance is in their hearts to take on the task and responsibility to grow, rather than just talking out loud about inheritance," Fan said.
"It feels great to compete with my young teammates side by side. I hope these young athletes could participate in the World Cup, World Championships, the Olympics step by step and achieve better results."
Short track competitions are currently the most popular winter sports races in China, as the stadium hosting Chinese athletes often has near-capacity attendance drawn by the chance to witness the star-studded national squad.
Saturday's race saw Team China bag four silver and one bronze medals. The competitions will continue on Sunday, including a highly-anticipated men's 5,000-meter relay final.
A Xinjiang hospital's Key State Lab has signed a deal with the Kazakhstan National Medical Science Center to enhance cooperation on prevention and treatment of high incidence diseases in Central Asia. Additionally, the Xinjiang Medical University Hospital also signed a parallel agreement for surgery and organ transplantation. The signing marks an increased role for China in helping improving the health conditions of Central Asian countries with the support of the China Organ Transplant Development Foundation.
The deal was signed by the Kazakhstan center with The First Affiliated Hospital of Xinjiang Medical University and the hospital's Key State Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, at the 7th China-International Organ Donation Conference and the Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development in Nanning, South China's Guangxi Zhuang Autonomous Region on Saturday.
After the signing of the deal, Kazakhstan will send medical personnel to study at the Xinjiang Medical University hospital and Key State Laboratory specifically for research and treatment against high incidence diseases in Central Asia, Wen Hao, head of the Key State Lab of Xinjiang Medical University, told the Global Times on Saturday. The laboratory and the hospital are well-equipped and host a wide range of departments, "thus we can answer almost any technical request from the Kazaks. who are also thrilled about it," Wen said.
Wen said that the Key State Laboratory was opened in 2017. It is actively working with five Central Asian neighboring countries on training, as well as studying and treating major diseases in these areas, such as cervical cancer and esophageal cancer. Additionally, zoonotic cardiovascular diseases, diabetes, and cerebrovascular diseases are also prevalent and pose the greatest threat to the people's health in Central Asia.
Ever since the Key State Laboratory was established, it has been working to strengthen cooperation with Central Asian countries. Wen noted that China is ahead of neighboring countries in terms of scale, quality, and national standards of medical care, which is one of the reasons these countries are interested in working with China. .
In July of this year, the Xinjiang hospital assisted the Kazakhstan National Medical Science Center in successfully treating a patient with alveolar Echinoccosis by using Exvivo Liver Resection & Autotransplantation (ELRA) for the first time.
Wen stated that in active response to the Belt and Road Initiative, his lab and hospital had dispatched a team of medical experts to Central Asian countries, such as Kazakhstan, Kyrgyzstan and Uzbekistan. Through medical technology exchanges, hosting bilateral academic forums, and establishing technology promotion and training bases, the hospital aims to continuously deepen and broaden cooperation with these Central Asian countries, seeking to enable people in these countries to access and benefit from high-quality medical resources.
In May of this year, China and five Central Asian countries jointly signed the Xi'an Declaration of the China-Central Asia Summit, which was held in Chinese city of Xi'an. In the declaration, all sides agreed to further deepen health and medical cooperation, promote the construction of traditional Chinese medicine centers, and carry out herbal planting and processing cooperation to create a healthy "Silk Road."
After China has improved its own work on organ donation and transplantation, sharing expertise with countries participating in the Belt and Road Initiative has also become very important. Aims include pushing forward their development in this regard, and assisting them with the development of local medical systems and technology, Huang Jiefu, chairman of China Human Organ Donation and Transplantation Committee and Chair of COTDF Advisory Board told the Global Times on Saturday.
Wen said that in recent years, countries such as India, South Korea, Japan, and some Western countries, have been trying to exert influence over Central Asia. He mentioned that Abay Baigenzhin, Chairman of the Management Board of Kazakhstan National Medical Science Center, told him that cooperation with Western countries usually involves big promises but little action. However, after enhancing cooperation with China, Kazakhstan appreciated that China not only kept its promises, but also had the ability to implement projects.
Wen also noted that now China is offering preferential policies for medical students from Central Asian countries, which has facilitated medical exchanges between China and the region. "Such cooperation is helpful for people-to-people exchanges between China and those countries; and there is no basis for attacking or smearing efforts to help people cure diseases."
"In the next two years leading up to 2025, we should expect to see more practical cases of collaboration, inspiring stories, and data to support our cooperation in organ transplantation and donation with Central Asian countries. These developments will further bolster our contributions to the prevention, diagnosis, and treatment of prevalent diseases in Central Asia, as well as the promotion of public health across the region regions," said Wen.
China's first mass-produced WZ-16 turboshaft engines were recently delivered, marking yet another achievement in the country's aero engine sector, which used to trail behind the global top standard, experts said on Sunday.
A delivery conference was held in Harbin, Northeast China's Heilongjiang Province, on Friday, according to a press release from the state-owned Aero Engine Corporation of China (AECC) published on its WeChat account on Saturday.
The press release did not give details on the delivery, including the engine's customers or the number of engines delivered. At least three engines can be seen in a photo attached to the press release.
This marks a key step in the industrial development of the AECC's aero engine products for civilian purposes, and fully displays China's capabilities in research and development as well as marketing in this high technology sector, the AECC said.
The WZ-16 is a latest type of turboshaft engine that was strictly developed and certified in accordance with airworthiness regulations, the AECC said, noting that with a takeoff power of more than 1,240 kilowatts, a weight of less than 223.5 kilograms, a fuel consumption rate of less than 294 grams per kilowatt-hour and a service ceiling of 6,000 meters, the engine's overall performance has reached an internationally advanced level with high reliability and a long overhaul interval.
Having obtained type certification in October 2019 and production certification in March 2021, the WZ-16 can be equipped by seven ton-class twin-engine helicopters such as the AC352 (also known as the Z-15) and see wide applications in fields such as search and rescue, offshore drilling operations, personnel transport, medical aid and commercial flights, the company said.
The Z-15 medium-sized, multipurpose helicopter was awarded a qualification certificate by the Civil Aviation Administration of China in July 2022, marking the successful development of this type of chopper, which is now eligible to enter China's civilian market, the Global Times learned from the state-owned Aviation Industry Corporation of China, the helicopter's maker.
China's aero engine technology used to lag behind the world's top standard for decades, and now it is seeing significant achievements in many fields, a Chinese aviation expert who requested anonymity told the Global Times on Sunday.
In recent years, China's top military aircraft like the J-20 fighter jet and the Y-20 transport aircraft have converted to using domestically developed turbofan engines, and now civilian helicopters are getting advanced turboshaft engines, the expert said, noting that Chinese aero engine developers' efforts are beginning to bear fruits, and that more advanced engines are likely under development.
China saw more than 40,200 deceased organ donations from 2015 to the end of 2022, with 120,100 major organs donated. Additionally, more than 6.55 million people have voluntarily registered for organ donations, according to the China Organ Transplant Development Foundation (COTDF).
The COTDF revealed the figure at the 7th China-International Organ Donation Conference and the Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development, which kicked off in Nanning, South China's Guangxi Zhuang Autonomous Region, on Saturday.
Currently, China ranks second in the world and first in Asia in terms of the number of organ donations, benefiting numerous patients in need. The COTDF said that 5,628 deceased organ donations were made in 2022, an increase of 6.75 percent compared to 2021.
More than 20,000 organ donations are made in Chinese mainland each year, ranking second in the world in terms of data. However, organ donors per million people (PMP) is less than 4 percent, which is far from satisfactory compared to the 47 percent in developed countries, Huang Jiefu, chairman of China Human Organ Donation and Transplantation Committee and chair of the COTDF Advisory Board, told the Global Times on Saturday.
He pointed out that there are not enough hospitals in China to satisfy patients' demand for organ transplants. "China currently has only slightly more than 70 hospitals that perform heart and lung transplants. Thus, there is still a shortage of doctors and hospitals to meet the needs of the people," said Huang.
In October, China's State Council held an executive meeting that adopted a draft revision to the regulations on donation and transplantation of human organs.
The government aims to establish a system for tracing and supervising the whole procedure of donating and transplanting human organs. It will enhance ethical reviews on how human organs are obtained and crack down on crimes involving human organs, according to the meeting.
Talking about the revision, Huang used the phrase "scraping poison off the bone" to describe the determination in China's organ donation reform.
He said that under the leadership of the central government, this reform has achieved significant victories and has been widely recognized by the international community. The revision of the regulation demonstrates the Party and the country's emphasis on organ donation, providing strong legal protection for the high-quality development of the organ donation cause, said Huang.
Huang said that the word "donation" carries special meaning. With the coming of the regulation, organ donations will be more transparent, and it also calls for more people to get involved in organ donations and transplants. In the future, it is hoped that China's organ transplantation technology will spread to more countries in the Belt and Road Initiative via the Organ Donation and Transplant under the Framework of the Belt and Road Initiative, said Huang.
Talking about China's recent achievements in organ transplantation, John Fung, president-elect of the Transplantation Society, told the Global Times that in terms of survival, China meets international standards.
"The primary accomplishment of China's transplant efforts is that a country that had very limited transplants 30 years ago is now able to compete with any other transplant program in the world in terms of quality," said Fung.
However, Fung also mentioned that the primary challenge in China is that "it has a very large population and still not enough access to transplants. There are many barriers to transplants for the common people in terms of costs as well as a shortage of organs."
Yet he said that China is getting there as the trajectory of donations in the country is increasing fast, thus he is confident that five years from now China will move to a much higher rate of donation.
The Belt & Road Symposium on Organ Donation and Transplantation International Cooperation Development held a launch ceremony, during which those in attendance agreed to establish a series of action plans in the areas of leadership, management, quality control and technological innovation in organ donations and transplantations based on the principles outlined by WHO Guiding Principles on Human Cell, Tissue and Organ Transplantation.
Through continuous strengthening of interaction, deepening of mutual trust, and fostering of friendship, the goal of self-sufficiency in organ donation will be achieved.
Fung also mentioned that there is an organized conspiracy on the international stage that tries to play down the accomplishments of China's organ donation experience, by feeding misinformation about transplants in China to further damage the country's reputation.
For example, a new wave of accusations of "organ harvesting" in China has emerged. Following some Western media reports from the China Tribunal, which accused the Chinese government of "harvesting organs from Falun Gong practitioners" and Uygurs "detained in camps" since June 2019, VICE magazine's France version also released a new report on the same topic on June 19, offering more so-called "evidence."
By digging into those stories, the Global Times has found out that such claims are lies interwoven by members of the Falun Gong cult, separatists from Xinjiang and overseas anti-China forces with the purpose to further paint China as a devil mistreating minorities in Xinjiang, to smear the country's organ transplantation and donation system and its anti-terrorism work in Xinjiang, and to instigate the international community to further pressure China.
In response to this recent slander, Huang said that China's reform on organ transplantation is to keep friends close and keep enemies closer. "You can never wake up someone who is pretending to be asleep… we are not afraid of those slanders, as long as what we are doing is justified and is on the right course."
Fung suggested that more publications about "China's organ transplantation be disseminated globally for people to understand that China complies with international standards and that their outcomes for transplantations are as good as anybody else's. As transplantation society president I will do my best to make it more open for the world to understand and appreciate w
